{"id":"W2100771859","doi":"10.1517/13543784.2015.1009629","title":"Investigational drugs for the treatment of spinal cord injury: review of preclinical studies and evaluation of clinical trials from Phase I to II","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Spinal Cord Injury Research","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Toronto Western Hospital; University Health Network","funders":"AOSpine; Ontario Neurotrauma Foundation; European Commission; Acorda Therapeutics; Hadassah Medical Organization; Medtronic","keywords":"Medicine; Clinical trial; Riluzole; Spinal cord injury; Tolerability; Intensive care medicine; Neuroprotection; Pharmacology; Gabapentin; Adverse effect; Spinal cord; Disease; Internal medicine; Amyotrophic lateral sclerosis; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.02217905,0.0005857773,0.005784575,0.0003673082,0.0001299969,0.00001086212,0.000369251,0.0003732323,0.0001263341],"category_scores_gemma":[0.04376796,0.0003551796,0.001256593,0.0006192171,0.001314043,0.00009154873,0.0001577323,0.0003689747,0.000009302649],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004017579,"about_ca_system_score_gemma":0.006191196,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005056382,"about_ca_topic_score_gemma":8.271962e-7,"domain_scores_codex":[0.9863154,0.003681725,0.005782137,0.0008751936,0.003084703,0.0002607988],"domain_scores_gemma":[0.9770662,0.01316131,0.003594231,0.0009882718,0.004567368,0.000622574],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.006080949,0.000929579,0.00000894619,0.01297217,0.001558613,1.722422e-7,0.0002987862,7.742445e-7,0.000009476485,0.001156778,0.03026365,0.9467201],"study_design_scores_gemma":[0.004889542,0.03650551,0.00004324268,0.1212288,0.001574179,0.000002977301,0.0001616457,0.0001334671,0.0001414502,0.002156382,0.8329087,0.0002541064],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00134517,0.980908,0.00001824427,0.005232259,0.001083729,0.009748873,0.001599501,0.00001498568,0.00004920156],"genre_scores_gemma":[0.00008513444,0.9872106,0.004800772,0.0009208368,0.001831858,0.003125692,0.001904651,0.00005603594,0.000064375],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.946466,"threshold_uncertainty_score":0.99989,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.7987099318314077,"score_gpt":0.7059770694690723,"score_spread":0.09273286236233536,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}